Title of the Talk: Application of machine learning to identify new potential drug candidates for Dravet syndrome
Dravet syndrome is an autosomal dominant genetic disorder which causes a catastrophic form of epilepsy. It is characterized by prolonged febrile and non-febrile seizures within the first year of life, which progress to other seizures, and psychomotor delay. In most cases, the mutations associated with the disease are not hereditary (nonsense mutations in the SCN1A gene, which codifies for NaV1.1). Accordingly, non selective anticonvulsant sodium channel blockers are known to aggravate seizures and status epilepticus in Dravet patients. Taking inspiration on recent success in the development of small molecules capable of selectively inhibiting the NaV1.7 subtype, we currently pursue the identification of highly selective NaV1.2 or NaV1.6 blockers that do not inhibit NaV1.1, as potential treatments for Dravet syndrome. For that purpose, machine learning models based on random subspace approximations, linear classifiers and ensemble learning, have been developed using NaV1.2 and NaV1.6 as targets and NaV1.1 as antitarget. The models have been applied in retrospective virtual screening campaigns, with very good enrichment metrics, and are currently applied complementary with structure-based approximations in the prospective virtual screening for new potential drug candidates against Dravet syndorme.
Prof. Alan Talevi was born in Buenos Aires, 1980. He obtained his Pharmacy degree in 2004 and completed his PhD studies in 2007, both at the University of La Plata (UNLP, Argentina). Among other recognitions, he obtained the award for the best PhD thesis on Computational Chemistry from the Argentinean Chemical Society (2008), a Pacifichem Young Scholar Award (USA, 2010) and the Award to Scientific and Technological Production from UNLP (2016). Since 2010, he holds a permanent position at the Argentinean Council of Scientific and Technical Research (CONICET), where he currently occupies an Independent Researcher position, and since 2012 he is the professor in charge of the Biopharmacy/Pharmacokinetics course at the Faculty of Exact Sciences, UNLP. He has published over 70 articles in periodicals and more than 30 book chapters, mostly in the fields of machine learning, drug discovery and biopharmacy. He was elected Head of the Department of Biological Sciences of the Faculty of Exact Sciences, UNLP, between 2015 and 2017. In 2018 he became the Head of the Laboratory of Bioactive Research and Development (LIDeB, UNLP). External reviewer for several agencies and universities, including the Argentinean National Institute of Cancer, Argentinean National Agency of Scientific and Technical Promotion, Argentinean Ministry of National Education, University of La República (Uruguay), University of Buenos Aires (Argentina), University of Córdoba (Argentina), University of Mar del Plata (Argentina), the National Agency of Scientific and Technical Promotion (Uruguay), the United Nations University, the National Science Center (Poland) and the “Victor Babes” University of Medicine and Pharmacy (Romania), CONCYTEC (Perú), and UK Research and Innovation (UK). Reviewer of more than 80 periodicals (https://publons.com/researcher/1667052/alan-talevi/), mostly in the fields of Cheminformatics, Drug Discovery, Drug Design and Pharmacology, including the Nature Communications, Scientific Reports, Journal of Medicinal Chemistry, Journal of Chemical Information and Modelling, Journal of Molecular Graphics and Modelling, PLoS One, Expert Opinion on Drug Delivery, Expert Opinion on Drug Discovery, Expert Opinion on Drug Metabolism and Toxicology, European Journal of Medicinal Chemistry, European Journal of Pharmacology, International Journal of Pharmaceutics, Journal of Pharmacy and Pharmacology. Outstanding reviewer of the European Journal of Medicinal Chemistry, European Journal of Pharmacology and Neuropharmacology, among others. Member of the editorial board of the Latin American Journal of Pharmacy (from 2014 and continues) and the Journal of Pharmacy and Nutrition Sciences. Guest editor of Mini-Reviews in Medicinal Chemistry, Frontiers in Chemistry and Current Drug Safety. Editor of the Antiepileptic Drug Discovery Novel Approaches volume of the Springer Protocols series (2016), and also of ADME Processes in Pharmaceutical Sciences Dosage, Design, and Pharmacotherapy Success (Springer, 2018). Chief Editor of the ADME Encyclopedia (Springer, 2021) and of the incoming Springer Nature Computer-Aided Drug Discovery and Design series.
Title of the Talk: Vibrotactile Coordinated Reset Stimulation for the Therapy of Parkinson’s Disease: Theory and Clinical Results
Abnormally strong synchronization of neuronal activity is a hallmark of several brain disorders, such as Parkinson’s disease (PD). In PD patients, permanent high-frequency deep brain stimulation suppresses symptoms during stimulus delivery. A qualitatively different, theory-based approach uses dedicated patterns of electrical stimuli delivered to brain tissue to cause a desynchronization-induced decoupling of oscillatory neurons, intending to move neural networks from attractors with abnormal neural synchrony to more physiological (desynchronized) attractors. Corresponding cumulative and long-lasting therapeutic and desynchronizing effects were demonstrated in animal and clinical studies.
By replacing invasively delivered electrical bursts with non-invasively administered vibratory bursts, we have developed a non-invasive approach: Vibrotactile Coordinated Reset (vCR) stimulation delivered to the fingertips was designed to treat PD patients by inducing long-lasting desynchronization. In a feasibility study, six PD patients were treated with vCR stimulation delivered for four hours per day for three months. Patients’ conditions were evaluated after medication withdrawal (‘off medication’) by means of standard clinical scores and EEG recordings before and after the 3-month vCR treatment. In accordance with vCR-related computational studies, months-long vCR therapy causes a statistically and clinically significant reduction of PD symptoms off medication together with a significant reduction of high beta (21-30 Hz) power in the sensorimotor cortex. The ultimate goal of this approach is to induce sustained symptom relief by non-invasively delivering desynchronizing stimulus patterns only regularly or occasionally.
Peter A. Tass studied medicine (MD, Ulm and Heidelberg Univ., Germany), physics (PhD, Stuttgart Univ., Germany), and mathematics (diploma, Stuttgart Univ.) and made a Habilitation in physiology (RWTH Aachen University, Germany). Since 2017 he is Professor of Neurosurgery in the Department of Neurosurgery, Stanford University Medical School, Stanford, CA, USA. Peter A. Tass investigates and develops neuromodulation techniques for understanding and treating neurologic conditions such as Parkinson’s disease, epilepsy, dysfunction following stroke and tinnitus. He creates invasive and non-invasive therapeutic procedures by means of comprehensive computational neuroscience studies and advanced data analysis techniques. Peter A. Tass has published more than 160 peer-reviewed papers, is inventor or co-inventor on more than 270 patents and received a number of national and international awards. Stanford lab homepage: http://med.stanford.edu/tass-lab.html
Title of the Talk: What to expect? Anticipation of contours and motion in early visual cortical circuits
To be announced
Currently Full Professor for Systems Neuroscience at the Brain Institute of the Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. Director of the Brain Institute of the Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. Scientific experience: Doctorate in medicine from Johann-Wolfgang Goethe Universität Frankfurt/Main and Max-Planck Institute (MPI) for Brain Research; Postdoc, MPI for Brain Research, Department for Neurophysiology; Research assistant, MPI for Brain Research, Department of Neurophysiology; Otto-Hahn fellowship at Karolinska Institute, Department of Neuroscience, Division of Neuroanatomy and Brain Development (Prof. Innocenti), Stockholm, Sweden; Independent Research Group Leader, MPI Brain Research, Frankfurt.
Title of the Talk: To be announced
To be announced
Full Professor, Computer Science Department, University of São Paulo (USP), São Carlos, Brazil. Vice president of the Brazilian Computer Society. Prof. André de Carvalho has more than 300 publications in data science, machine learning and data mining, including 10 best papers awards from conferences organized by ACM, IEEE and SBC. Prof. André de Carvalho supervised/co-supervised more than 25 PhD students in different Universities in Brazil and Portugal and more than 15 Postdocs. He has been in the Editorial Board and Program Committee of some of the main conferences and Journals in Artificial Intelligence, Data Science, Data Mining, Machine Learning, like AAAI, KDD, ECML/PKDD, IJCAI and SDM. He is a member of the International Association for Statistical Computing (IASC) Council and Director of the Center of Machine Learning in Data Analysis, University of São Paulo.
Title: A Cognitive Architecture for Object Recognition in Video
This talk describes our efforts to abstract from the animal visual system the computational principles to recognize objects in video without using labels and decreasing the computational bandwidth required. We develop a hierarchical, distributed architecture of dynamical systems that self-organizes and mimics the foveal vision in humans using an empirical Bayes criterion with sparseness constraints and dual state estimation. The interpretation of the images is mediated through causes that flow top down and change the priors for the bottom up processing. We will present preliminary results of a top down focus of attention that is capable of recognizing objects in partial occluded images.
Jose C. Principe (M’83-SM’90-F’00) is a Distinguished Professor of Electrical and Computer Engineering and Biomedical Engineering at the University of Florida where he teaches advanced signal processing, machine learning and artificial neural networks (ANNs) modeling. He is the Eckis Endowed Professor and the Founder and Director of the University of Florida Computational NeuroEngineering Laboratory (CNEL) www.cnel.ufl.edu . His primary area of interest is processing of time varying signals with adaptive neural models. The CNEL Lab has been studying signal and pattern recognition principles based on information theoretic criteria (entropy and mutual information)
Dr. Principe is an IEEE Fellow and received the prestigious IEEE Neural Network Pioneer Award in 2012. He was the past Chair of the Technical Committee on Neural Networks of the IEEE Signal Processing Society, Past-President of the International Neural Network Society, and Past-Editor in Chief of the IEEE Transactions on Biomedical Engineering. Dr. Principe has more than 900 publications, and an H-index of 82 (Google Scholar). He directed 98 Ph.D. dissertations and 65 Master theses. He wrote in 2000 an interactive electronic book entitled “Neural and Adaptive Systems” published by John Wiley and Sons and more recently co-authored several books on “Brain Machine Interface Engineering” Morgan and Claypool, “Information Theoretic Learning”, Springer, and “Kernel Adaptive Filtering”, Wiley.
Title: To be announced
To be announced
Angela TS Wyse is Full Professor of Biochemistry at the Federal University of Rio Grande do Sul (UFRGS), Member of the Brazilian Academy of Sciences and was elected, in 2018, Member of the World Academy of Sciences (TWAS, in the area of Medical and Health Sciences). She obtained her Master and PhD degrees in Biochemistry at UFRGS. supervised 13 post-doctoral fellows, 28 PhD and 43 MSc students, some of whom currently hold academic research positions at universities in Brazil and in the USA. Her research work focuses on the neurotoxic mechanisms of homocysteine and other compounds accumulated in inborn errors of metabolism, encompassing multiple experimental approaches ranging from neurochemistry to behavior. She also investigates possible neuroprotective agents, such as antioxidants, folic acid, creatine and physical exercise on behavioral and/or neurochemical alterations in experimental animal models of neurodegenerative disorders. Professor Wyse has shown that homocysteine, an amino acid accumulated in classical homocystinuria and known to be a risk factor for ischemia and neurodegenerative diseases, causes brain and heart damage by affecting energy metabolism, Na+,K+-ATPase activity and neural excitotoxicity. She developed a well-accepted experimental model of hyperhomocysteinemia that has been employed to perform biochemical and behavioral studies to unveil the neurotoxicity of homocysteine. Her contributions have been cited and acknowledged by researchers all over the world; experimental findings show correlation with symptoms in patients affected with classical homocystinuria. Her studies also help the understanding of lipid and DNA damage present in homocystinuric patients and show potential to improve medical practice. She has recently opened a line to investigate the neurobiology of menopause, ranging from biochemistry to behavior in experimental models, with focus on development of alternative treatment to fight brain damage found in menopause. She has published more than 360 scientific papers in international peer review journals that have received an expressive number of citations. Professor Wyse’s contributions to the development of basic health sciences have been recognized by many awards, including “CAPES- Elsevier Award 2014” and “Pesquisador Gaúcho Award 2018”, from the State Research Foundation (FAPERGS). Convinced that access to science and education are pillars to citizenship, she develops a social project for underprivileged children of the public school of Porto Alegre stimulating interest for science. She published a book of poetry “Neuropoesia” (Neuropoetry)
To be announced
To be announced
To be announced
To be announced